WO1994024932A1 - Diagnostic impedance measuring system - Google Patents

Diagnostic impedance measuring system Download PDF

Info

Publication number
WO1994024932A1
WO1994024932A1 PCT/US1994/004035 US9404035W WO9424932A1 WO 1994024932 A1 WO1994024932 A1 WO 1994024932A1 US 9404035 W US9404035 W US 9404035W WO 9424932 A1 WO9424932 A1 WO 9424932A1
Authority
WO
WIPO (PCT)
Prior art keywords
impedance
electrodes
signal
reference electrodes
probe
Prior art date
Application number
PCT/US1994/004035
Other languages
French (fr)
Other versions
WO1994024932B1 (en
Inventor
Paul C. Nardella
Original Assignee
Medical Scientific, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medical Scientific, Inc. filed Critical Medical Scientific, Inc.
Priority to AU66655/94A priority Critical patent/AU6665594A/en
Publication of WO1994024932A1 publication Critical patent/WO1994024932A1/en
Publication of WO1994024932B1 publication Critical patent/WO1994024932B1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/05Detecting, measuring or recording for diagnosis by means of electric currents or magnetic fields; Measuring using microwaves or radio waves 
    • A61B5/053Measuring electrical impedance or conductance of a portion of the body
    • A61B5/0538Measuring electrical impedance or conductance of a portion of the body invasively, e.g. using a catheter
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/05Detecting, measuring or recording for diagnosis by means of electric currents or magnetic fields; Measuring using microwaves or radio waves 
    • A61B5/053Measuring electrical impedance or conductance of a portion of the body
    • A61B5/0535Impedance plethysmography

Definitions

  • This invention relates generally to the determination of the relative location of a probe within a human or animal body. More particularly, the present invention relates to a device and method for determining the relative location of a probe within the human or animal body by measuring or monitoring the biological impedance located adjacent to the distal end of the probe.
  • insufflation needles are commonly known and are used during certain surgical procedures to insufflate the abdominal cavity with a vapor or gas.
  • insufflation needles comprise an inner cannula and an outer cannula.
  • the inner cannula extends beyond the distal tip of the outer cannula and typically has a blunt distal end.
  • the outer cannula has a needle point with a cutting tip for easy penetration of the skin and tissue underlying the abdominal wall.
  • the outer cannula expands into a hub section at the proximal end that houses a biasing mechanism.
  • the inner cannula is disposed within the outer cannula and includes a hollow tube having a distal end that is normally blunt, to avoid puncturing intra-abdominal structures.
  • the distal end of the inner cannula has a side port hole located above the distal tip of the outer cannula through which vapor or gas may flow.
  • insufflation needle in the typical manner has several potential drawbacks.
  • the surgeon must estimate the location of the needle within the abdomen as the needle is being inserted. This approach can result in the accidental puncture of an intra- abdominal structure, such as the bowel, liver or major blood vessel, by the cutting tip of the outer cannula.
  • an object of this invention is to provide an impedance measuring system for use with a surgical probe to measure the relative impedance of intra-abdominal structures.
  • Another object of the invention is to provide an impedance measuring system that is easily adaptable to surgical probes.
  • Still another object of the invention is to provide a reliable means of determining whether an internal cavity has been reached.
  • Yet another object of the invention is to provide an additional safeguard against the accidental puncture of intra-abdominal structures.
  • an impedance measuring system having an elongate tissue-penetrating probe member with a plurality of axially spaced reference electrodes disposed about a distal portion of the probe.
  • the reference electrodes measure the impedance of the biological tissue adjacent to each electrode.
  • a first comparator element compares the measured impedance of at least a first and a second of the reference electrodes, and the comparator generates a first signal indicative of the impedance difference between the two electrodes.
  • a second comparator element compares the measured impedance between either the first or second electrode and one additional electrode, and generates a second signal indicative of the impedance difference between the two electrodes.
  • a third comparator element compares the first and second signals and generates a third signal indicative of the impedance difference between the two signals.
  • the third signal can be either a NULL signal, which indicates that the impedance difference between the first and second signals is zero, or a non-NULL signal, which indicates that the difference between the first and second signals is greater or less than zero.
  • the impedance measuring system can be used in conjunction with a generator that supplies the reference electrodes with a diagnostic level of energy, insufficient to cut or cauterize biological tissue.
  • a signal evaluation element is also used in conjunction with the foregoing elements to determine the relative position of the probe within a patient's body.
  • the evaluation element can comprise an audible signal that sounds whenever the third signal is a NULL signal.
  • Other embodiments include a single comparator element that compares the impedance of the biological tissue measured at the electrodes and generates an output signal indicative of the impedance difference.
  • the probe member may be an insufflation needle.
  • Figure 1 illustrates the diagnostic impedance measuring system of the present invention.
  • Figure 2 shows a schematic circuit diagram of the impedance measuring circuit of the present invention.
  • Figure 3 is a diagrammatical view of a portion of the abdomen showing the insertion of the insufflation needle of Figure 1.
  • Figure 4 is a diagrammatical view of a portion of the insufflation needle piercing the abdominal wall.
  • Figure 5 is a diagrammatical view of the insufflation needle positioned within the abdominal cavity.
  • FIG 1 illustrates the electrosurgical probe and impedance measuring system
  • the system 10 comprises a power source 30, a reservoir 32, an elongate probe 12, a comparator element 42 and an evaluation element 44.
  • the probe 12 is an insufflation needle comprising an outer cannula 14 having a cutting tip 18, an inner cannula 16 having a side port hole 40, a biasing mechanism 24, reference electrodes 20A-C, and a valve 26.
  • the power source 30 is in electrical communication with the reference electrodes 20A-C and the evaluation element 44.
  • the device is adapted to deliver an insufflation vapor or gas from reservoir 32 through the probe 12 to an intrabody cavity such as the abdomen.
  • the reference electrodes 20A-C are in electrical communication with the comparator element 42, and the comparator element 42 communicates with the evaluation element 44 via signal 50.
  • Figure 1 illustrates comparator element 42 and evaluation element 44 adjacent the distal end of the probe 12 for ease of illustration.
  • comparator element 42 and evaluation element 44 are associated with power source 30.
  • the probe member 12 is an elongate member having a hub portion or handle 22 at its proximal end.
  • An outer cannula 14 preferably is integral or associated with the handle and extends from the handle. The distal end of the outer cannula 14 has a chamfered end forming a cutting tip 18.
  • An inner cannula is disposed within the outer cannula 14.
  • the inner cannula is also an elongate member having a proximal end adjacent to the handle 22 and a distal end that is able to protrude from the distal end of the outer cannula 14.
  • the inner cannula 16 is biased to a position whereby it extends from the distal end of the outer cannula 14.
  • the biasing force can be provided by a mechanism, e.g., a helically coiled spring 24, that is coupled to the proximal end of the inner cannula 16.
  • a mechanism e.g., a helically coiled spring 24, that is coupled to the proximal end of the inner cannula 16.
  • the inner cannula 16 preferably has a blunt distal end that is biased to extend beyond the outer cannula 14.
  • the distal end of inner cannula 16 has a side port 40 for discharging an insufflation gas, preferably CO2 gas, into an intra-body cavity.
  • an insufflation gas preferably CO2 gas
  • the inner cannula 16 is subjected to an axial load, such as by contact with tissue, it is retracted within outer cannula 14 and the side port 40 is occluded and is unable to deliver the insufflation gas to the intra-body cavity.
  • the inner cannula is again biased to an extended position and a gas is able to be delivered through port 40.
  • the delivery of an insulation gas from reservoir 32 through the probe 12 can be achieved by methods well known in the art.
  • a valve 26 can be used to control the flow rate of the insufflation gas.
  • the probe 12 preferably has disposed about its distal end three reference electrodes 20A-C.
  • the electrodes 20A-C can be placed about the outer cannula 14 in any conventional manner, but an annular orientation of each of the three electrodes is preferred. Those of ordinary skill in the art will realize that the electrodes need not be annular, but can also comprise helical or point electrodes.
  • the electrodes 20A-C can be placed anywhere along the probe 12, but are preferably disposed in close proximity to the cutting tip 18 as illustrated in Figure 1.
  • the electrodes 20A-C are preferably electrically isolated from each other and from the probe 12.
  • the reference electrodes are spaced about 2 to 6 mm apart, but it should be understood that the spacing may vary depending upon the depth and type of the biological tissue through which the probe must penetrate, and the sensitivity required of the electrodes.
  • the present system 10 can also be used to determine the type and relative location of different layers of tissue.
  • the electrodes are preferably made from a medically compatible, highly conductive material such as gold, silver, or platinum. However, it is also possible to use less conductive electrode material such as stainless steel, or other highly resistive materials such as titanium. Alternatively, the electrodes can be made of an electrically conductive plating (e.g., gold, silver, or platinum) disposed upon an insulating material such as a polymer.
  • the electrosurgical generator can be any one of a variety of commercially available units.
  • the electrosurgical generator 30 is in electrical communication with the electrodes 20A-C via electrical leads (not shown).
  • the electrical leads can be placed within the outer cannula 14.
  • the leads can extend along the outside of the outer cannula 14, while being disposed within a non-conductive sheath.
  • the sheath can be made of any suitable non-conductive material such as rubber or plastic.
  • the reference electrodes 20A-C also are in electrical communication with the comparator element 42 which preferably is associated with power source 30.
  • the comparator element 42 compares the impedance measured by the electrodes 20A-C and generates an output signal 50 indicative of the difference in impedance adjacent the electrodes 20A-C.
  • the evaluation element 44 receives the output signal 50 and determines whether the relative position of the probe 12 is disposed in a medium with varying impedance, or whether it is disposed in a medium of uniform impedance. The evaluation element is described in further detail below.
  • the voltage delivered across the electrodes 20A-C is preferably between 0.5 V and 3.0 V, and most preferably is about 2.0 N.
  • the current delivered through the reference electrodes is preferably between 1.0 mA and 10 mA, and most preferably about 3.0 mA.
  • the amount of electrosurgical energy delivered through electrodes 20A-C is of a non-therapeutic magnitude and is not effective to cut or cauterize tissue.
  • Figure 2 depicts a schematic circuit diagram of the comparator element 42 according to a preferred embodiment of the invention.
  • the reference electrodes 20A-C of probe 12 are in electrical communication with comparator A and comparator B via electrical leads 60,62,64.
  • Comparator A generates a first signal 66 that is coupled to the positive (+) input terminal of comparator C
  • comparator B generates a second signal 68 that is coupled to the negative (-) or inverting input terminal of comparator C.
  • the comparator C generates a third signal 50 indicative of the difference between the first signal 66 and the second signal 68.
  • the third signal 50 is conveyed to the evaluation element 44.
  • the probe 12 of the present invention can be any type of tissue-penetrating probe.
  • probe 12 comprises an insufflation needle useful to penetrate tissue to access and insufflate a body cavity such as the abdomen.
  • the electrosurgical generator supplies a selected voltage to the reference electrodes 20A-C.
  • the voltage across each electrode will vary in relation to the impedance of the corresponding biological tissue. This voltage change will be conveyed by the electrical leads 60,62,64 to comparator A and comparator B.
  • comparator A and comparator B Those of ordinary skill in the art will understand that the voltages presented at the inputs of comparators A and B are representative of and a function of the impedance of the tissue adjacent the needle electrodes 20A-C.
  • the voltage representative of the tissue impedance adjacent the cutting tip 18 is conveyed from electrode 20A to the positive (+) input terminal of comparator A along electrical lead 60.
  • the tissue impedance measured at electrode 20B is conveyed to the negative (-) input terminal of comparator A and the positive (+) input terminal of comparator B via lead 62.
  • the tissue impedance measured at electrode C is conveyed to the negative (-) input terminal of comparator B via lead 64.
  • Comparator A generates a first signal 66 indicative of the difference in impedance between the electrodes coupled to the input terminals.
  • signal 66 is indicative of the difference in impedance between electrode 20A and electrode 20B.
  • the second signal 68 generated by comparator B is indicative of the difference in impedance between electrode 20B and electrode 20C.
  • Signals 66 and 68 are coupled to the positive (+) and negative (-) input terminals of comparator C, respectively.
  • Comparator C generates a third signal 50 in response to the two input signals 66,68.
  • the third signal 50 is indicative of the difference in impedance between the first and second signals 66,68.
  • the third signal 50 can be either a NULL or a non-NULL signal.
  • the comparator C will generate a NULL signal when the first and second signals 66,68 are representative of substantially the same impedance value.
  • the comparator C will generate a non-NULL signal.
  • the third signal 50 is communicated to the evaluation element 44.
  • the evaluation element 44 can be any apparatus or device that indicates to the surgeon or system user the representative impedance value conveyed by signal 50.
  • the evaluation element 50 can provide an audible alarm that sounds when the signal 70 is either a NULL or a non-NULL signal.
  • Another embodiment can include a visual light, e.g., an LED, that blinks in the presence or absence of a NULL signal.
  • the evaluation element 44 can be an oscilloscope or a digital monitor. Other embodiments will be readily recognizable to one of ordinary skill in the art.
  • a NULL signal indicates that the probe 12 is in a medium of substantially homogeneous impedance while a non-NULL signal indicates that the electrodes 20A-C on probe 12 are in media of differing impedance.
  • a non-NULL signal indicates that the electrodes 20A-C on probe 12 are in different types of tissue, and that the probe has not fully penetrated the abdominal wall.
  • a NULL signal it is probable that the probe has penetrated the abdominal wall and that electrodes 20A-C are in the same medium, i.e., within the abdominal cavity.
  • Figures 3-5 depict cross-sectional side views of the abdominal wall 80, and the penetration thereof by probe 12.
  • the side views show several fundamental structures of the abdominal wall, and the tissue components depicted in Figures 3-5 are only meant to illustrate the operating environment of the present invention.
  • the abdominal wall 80 generally comprises skin 52, fat 54, and peritoneum 58.
  • the abdominal cavity 56 and an internal abdominal structure 72 e.g., the intestine are also illustrated.
  • the blunt end of the inner cannula 16 is pressed against the skin 52 of the abdominal wall 80.
  • the needle 12 is then thrust downwardly, thereby disposing the inner cannula in the retracted position, while simultaneously exposing the cutting tip 18 of the outer cannula 14 to the skin 52.
  • the cutting tip 18 of the needle 12 pierces the skin 52 and fat 54 as it travels downwardly towards the cavity 56 (see Figure 4).
  • the needle then passes through the peritoneum 58 and into the abdominal cavity 56.
  • the axial load that biases the inner cannula 16 in the retracted position is removed, and the biasing mechanism 24 propels the inner cannula downward into the abdominal cavity 56, as shown by the arrow in Figure 5.
  • the inner cannula 16 is then disposed in the extended position, exposing the side port hole 40. A gas is then insufflated into the cavity 56 through the port hole 40.
  • the reference electrodes 20A-C measure the impedance of the tissue adjacent each respective electrode. Since different biological tissue types possess different inherent impedances, the three comparators A,B,C can detect different levels of impedance. For example, as the insufflation needle passes through the abdomen, the electrodes 20A-C are in contact with different biological tissue representative of different levels of impedance. Referring to Figure 4, electrode 20C can contact fat 54, while electrode 20B contacts skin 52, and electrode 20A contacts a gas. The electrodes 20A-C thus convey different impedance values to the input terminals of comparators A and B of Figure 2. As a result, the impedance signals 66 and 68 correspond to different impedance values, and the comparator C will generate a non-NULL signal.
  • the reference electrodes 20A-C will be exposed to a homogenous biological medium, as shown in Figure 5. This homogeneity of medium results in a NULL signal being generated by comparator C, since the reference electrodes 20A-C are measuring the same impedance level.
  • the generation of a NULL signal actuates the evaluation element 44.
  • the evaluation element 44 then either sounds an audible alarm or trips a visible light.
  • a disposable insufflation needle 12 can be used to pierce the abdominal wall and be positioned within the abdominal cavity, while simultaneously ensuring that internal structures are not damaged. The protection of internal organs is accomplished by the system of the present invention.
  • the reference electrodes 20A-C measure the impedance of the tissue adjacent the distal end of the outer cannula 14. The surgeon inserts the needle 12 until the comparator C generates a NULL signal indicative of a homogenous medium, e.g., placement within the abdominal cavity.
  • the NULL signal actuates the evaluation element 44 which, in turn, trips an audible or visual alarm.
  • the invention can be used to monitor the progress of the probe 12 through different tissue types and different tissue types. That is changes in impedance will indicate passage through fat tissue, muscle tissue, connective tissue, and other tissue types.

Abstract

A diagnostic impedance measuring system (10) having an elongate tissue-penetrating probe member (12) with a plurality of axially spaced reference electrodes (20A-C) disposed about a distal portion of the probe (12). The reference electrodes (20A-C) measure the impedance of the biological tissue adjacent each electrode. A comparator (42) compares the measured impedance of at least a first and a second of the reference electrodes (20A-C), and generates a first signal indicative of the impedance difference between the two electrodes. The comparator compares the measured impedance between either the first or second electrode and one additional electrode, and generates a second signal indicative of the impedance difference between the two electrodes. The comparator compares the first and second signals and generates a third signal indicative of the impedance difference between the two signals. The third signal communicates with a signal evaluation element that determines the relative position of the probe (12).

Description

DI AGNOSTIC IMPEDANCE MEASURING SYSTEM
Background of the Invention
This invention relates generally to the determination of the relative location of a probe within a human or animal body. More particularly, the present invention relates to a device and method for determining the relative location of a probe within the human or animal body by measuring or monitoring the biological impedance located adjacent to the distal end of the probe.
One type of probe generally used during endoscopic procedures is an insufflation needle. Insufflation needles are commonly known and are used during certain surgical procedures to insufflate the abdominal cavity with a vapor or gas. Typically, insufflation needles comprise an inner cannula and an outer cannula. The inner cannula extends beyond the distal tip of the outer cannula and typically has a blunt distal end. The outer cannula has a needle point with a cutting tip for easy penetration of the skin and tissue underlying the abdominal wall. The outer cannula expands into a hub section at the proximal end that houses a biasing mechanism. The inner cannula is disposed within the outer cannula and includes a hollow tube having a distal end that is normally blunt, to avoid puncturing intra-abdominal structures. The distal end of the inner cannula has a side port hole located above the distal tip of the outer cannula through which vapor or gas may flow. When the tip of the insufflation needle is subject to an axial load, as a result of contacting tissue on or within the abdominal wall, the blunt end of the inner cannula is forced within the outer cannula, exposing the sharp cutting end of the outer cannula. After the insufflation needle pierces the abdominal wall structures and enters the abdominal cavity, the inner cannula is propelled forward by the biasing mechanism. The insufflation gas is then able to be delivered through the port hole to the intra-body cavity.
The use of the insufflation needle in the typical manner has several potential drawbacks. The surgeon must estimate the location of the needle within the abdomen as the needle is being inserted. This approach can result in the accidental puncture of an intra- abdominal structure, such as the bowel, liver or major blood vessel, by the cutting tip of the outer cannula.
As the above described and other prior art systems have proven less than optimal, an object of this invention is to provide an impedance measuring system for use with a surgical probe to measure the relative impedance of intra-abdominal structures. Another object of the invention is to provide an impedance measuring system that is easily adaptable to surgical probes. Still another object of the invention is to provide a reliable means of determining whether an internal cavity has been reached. Yet another object of the invention is to provide an additional safeguard against the accidental puncture of intra-abdominal structures. Other general and more specific objects of this invention will in part be obvious from the drawings and descriptions which follow.
Summary of the Invention
These and other objects are attained by the invention which provides, in one embodiment, an impedance measuring system having an elongate tissue-penetrating probe member with a plurality of axially spaced reference electrodes disposed about a distal portion of the probe. The reference electrodes measure the impedance of the biological tissue adjacent to each electrode. A first comparator element compares the measured impedance of at least a first and a second of the reference electrodes, and the comparator generates a first signal indicative of the impedance difference between the two electrodes. A second comparator element compares the measured impedance between either the first or second electrode and one additional electrode, and generates a second signal indicative of the impedance difference between the two electrodes. A third comparator element compares the first and second signals and generates a third signal indicative of the impedance difference between the two signals.
The third signal can be either a NULL signal, which indicates that the impedance difference between the first and second signals is zero, or a non-NULL signal, which indicates that the difference between the first and second signals is greater or less than zero.
The impedance measuring system can be used in conjunction with a generator that supplies the reference electrodes with a diagnostic level of energy, insufficient to cut or cauterize biological tissue. A signal evaluation element is also used in conjunction with the foregoing elements to determine the relative position of the probe within a patient's body. According to one embodiment, the evaluation element can comprise an audible signal that sounds whenever the third signal is a NULL signal. Other embodiments include a single comparator element that compares the impedance of the biological tissue measured at the electrodes and generates an output signal indicative of the impedance difference.
In one particularly preferred embodiment, the probe member may be an insufflation needle.
Further embodiments of the invention will be evident from the above summary and from the description which follows. Brief Description of the Drawings
The foregoing and other aspects of the invention may be more fully understood from the following description, when read together with the accompanying drawings in which:
Figure 1 illustrates the diagnostic impedance measuring system of the present invention.
Figure 2 shows a schematic circuit diagram of the impedance measuring circuit of the present invention.
Figure 3 is a diagrammatical view of a portion of the abdomen showing the insertion of the insufflation needle of Figure 1.
Figure 4 is a diagrammatical view of a portion of the insufflation needle piercing the abdominal wall.
Figure 5 is a diagrammatical view of the insufflation needle positioned within the abdominal cavity.
Detailed Description of the Invention
Figure 1 illustrates the electrosurgical probe and impedance measuring system
10 for which a preferred embodiment of the present invention is suitable for use. The system 10 comprises a power source 30, a reservoir 32, an elongate probe 12, a comparator element 42 and an evaluation element 44. In one embodiment, the probe 12 is an insufflation needle comprising an outer cannula 14 having a cutting tip 18, an inner cannula 16 having a side port hole 40, a biasing mechanism 24, reference electrodes 20A-C, and a valve 26. The power source 30 is in electrical communication with the reference electrodes 20A-C and the evaluation element 44. The device is adapted to deliver an insufflation vapor or gas from reservoir 32 through the probe 12 to an intrabody cavity such as the abdomen.
The reference electrodes 20A-C are in electrical communication with the comparator element 42, and the comparator element 42 communicates with the evaluation element 44 via signal 50. Figure 1 illustrates comparator element 42 and evaluation element 44 adjacent the distal end of the probe 12 for ease of illustration. Preferably, comparator element 42 and evaluation element 44 are associated with power source 30. The probe member 12 is an elongate member having a hub portion or handle 22 at its proximal end. An outer cannula 14 preferably is integral or associated with the handle and extends from the handle. The distal end of the outer cannula 14 has a chamfered end forming a cutting tip 18. An inner cannula is disposed within the outer cannula 14. The inner cannula is also an elongate member having a proximal end adjacent to the handle 22 and a distal end that is able to protrude from the distal end of the outer cannula 14. Preferably, the inner cannula 16 is biased to a position whereby it extends from the distal end of the outer cannula 14. The biasing force can be provided by a mechanism, e.g., a helically coiled spring 24, that is coupled to the proximal end of the inner cannula 16. Although the inner cannula 16 is biased to extend from the outer cannula 14, the inner cannula 16 can be retracted upon the placement of a sufficient axial load on the distal end of the inner cannula.
The inner cannula 16 preferably has a blunt distal end that is biased to extend beyond the outer cannula 14. The distal end of inner cannula 16 has a side port 40 for discharging an insufflation gas, preferably CO2 gas, into an intra-body cavity. When the inner cannula 16 is subjected to an axial load, such as by contact with tissue, it is retracted within outer cannula 14 and the side port 40 is occluded and is unable to deliver the insufflation gas to the intra-body cavity. However, when the axial load is removed, the inner cannula is again biased to an extended position and a gas is able to be delivered through port 40.
The delivery of an insulation gas from reservoir 32 through the probe 12 can be achieved by methods well known in the art. Normally a valve 26 can be used to control the flow rate of the insufflation gas.
The probe 12 preferably has disposed about its distal end three reference electrodes 20A-C. The electrodes 20A-C can be placed about the outer cannula 14 in any conventional manner, but an annular orientation of each of the three electrodes is preferred. Those of ordinary skill in the art will realize that the electrodes need not be annular, but can also comprise helical or point electrodes. The electrodes 20A-C can be placed anywhere along the probe 12, but are preferably disposed in close proximity to the cutting tip 18 as illustrated in Figure 1.
Further, the electrodes 20A-C are preferably electrically isolated from each other and from the probe 12. The reference electrodes are spaced about 2 to 6 mm apart, but it should be understood that the spacing may vary depending upon the depth and type of the biological tissue through which the probe must penetrate, and the sensitivity required of the electrodes. The present system 10 can also be used to determine the type and relative location of different layers of tissue.
The electrodes are preferably made from a medically compatible, highly conductive material such as gold, silver, or platinum. However, it is also possible to use less conductive electrode material such as stainless steel, or other highly resistive materials such as titanium. Alternatively, the electrodes can be made of an electrically conductive plating (e.g., gold, silver, or platinum) disposed upon an insulating material such as a polymer.
A power source 30, such as an electrosurgical generator, supplies a diagnostic level of electrosurgical energy, e.g., radio frequency energy, to the reference electrodes 20A- C. The electrosurgical generator can be any one of a variety of commercially available units.
As noted, the electrosurgical generator 30 is in electrical communication with the electrodes 20A-C via electrical leads (not shown). The electrical leads can be placed within the outer cannula 14. Alternatively, the leads can extend along the outside of the outer cannula 14, while being disposed within a non-conductive sheath. The sheath can be made of any suitable non-conductive material such as rubber or plastic.
The reference electrodes 20A-C also are in electrical communication with the comparator element 42 which preferably is associated with power source 30. The comparator element 42, compares the impedance measured by the electrodes 20A-C and generates an output signal 50 indicative of the difference in impedance adjacent the electrodes 20A-C. The evaluation element 44 receives the output signal 50 and determines whether the relative position of the probe 12 is disposed in a medium with varying impedance, or whether it is disposed in a medium of uniform impedance. The evaluation element is described in further detail below.
The voltage delivered across the electrodes 20A-C is preferably between 0.5 V and 3.0 V, and most preferably is about 2.0 N. The current delivered through the reference electrodes is preferably between 1.0 mA and 10 mA, and most preferably about 3.0 mA. Preferably, the amount of electrosurgical energy delivered through electrodes 20A-C is of a non-therapeutic magnitude and is not effective to cut or cauterize tissue. However, it is possible to construct a system that is able to cut, coagulate, and measure tissue, while also monitoring the differential impedance.
Figure 2 depicts a schematic circuit diagram of the comparator element 42 according to a preferred embodiment of the invention. The reference electrodes 20A-C of probe 12 are in electrical communication with comparator A and comparator B via electrical leads 60,62,64. Comparator A generates a first signal 66 that is coupled to the positive (+) input terminal of comparator C, and comparator B generates a second signal 68 that is coupled to the negative (-) or inverting input terminal of comparator C. The comparator C generates a third signal 50 indicative of the difference between the first signal 66 and the second signal 68. The third signal 50 is conveyed to the evaluation element 44.
The probe 12 of the present invention can be any type of tissue-penetrating probe. In one preferred embodiment, however, probe 12 comprises an insufflation needle useful to penetrate tissue to access and insufflate a body cavity such as the abdomen. During use of probe 12 as an insufflation needle, the electrosurgical generator supplies a selected voltage to the reference electrodes 20A-C. As the probe 12 penetrates tissue, the voltage across each electrode will vary in relation to the impedance of the corresponding biological tissue. This voltage change will be conveyed by the electrical leads 60,62,64 to comparator A and comparator B. Those of ordinary skill in the art will understand that the voltages presented at the inputs of comparators A and B are representative of and a function of the impedance of the tissue adjacent the needle electrodes 20A-C.
In the embodiment illustrated in Figure 2, the voltage representative of the tissue impedance adjacent the cutting tip 18 is conveyed from electrode 20A to the positive (+) input terminal of comparator A along electrical lead 60. The tissue impedance measured at electrode 20B is conveyed to the negative (-) input terminal of comparator A and the positive (+) input terminal of comparator B via lead 62. The tissue impedance measured at electrode C is conveyed to the negative (-) input terminal of comparator B via lead 64.
Comparator A generates a first signal 66 indicative of the difference in impedance between the electrodes coupled to the input terminals. In the illustrated embodiment, signal 66 is indicative of the difference in impedance between electrode 20A and electrode 20B. Similarly, the second signal 68 generated by comparator B is indicative of the difference in impedance between electrode 20B and electrode 20C. Signals 66 and 68 are coupled to the positive (+) and negative (-) input terminals of comparator C, respectively. Comparator C generates a third signal 50 in response to the two input signals 66,68. The third signal 50 is indicative of the difference in impedance between the first and second signals 66,68. According to a preferred embodiment, the third signal 50 can be either a NULL or a non-NULL signal. The comparator C will generate a NULL signal when the first and second signals 66,68 are representative of substantially the same impedance value.
Likewise, when the two signals 66,68 are representative of different impedance values, the comparator C will generate a non-NULL signal. As illustrated, the third signal 50 is communicated to the evaluation element 44. The evaluation element 44 can be any apparatus or device that indicates to the surgeon or system user the representative impedance value conveyed by signal 50. For example, the evaluation element 50 can provide an audible alarm that sounds when the signal 70 is either a NULL or a non-NULL signal. Another embodiment can include a visual light, e.g., an LED, that blinks in the presence or absence of a NULL signal. Additionally, the evaluation element 44 can be an oscilloscope or a digital monitor. Other embodiments will be readily recognizable to one of ordinary skill in the art.
As noted, a NULL signal indicates that the probe 12 is in a medium of substantially homogeneous impedance while a non-NULL signal indicates that the electrodes 20A-C on probe 12 are in media of differing impedance. When a non-NULL signal is present, this is an indication that the electrodes 20A-C on probe 12 are in different types of tissue, and that the probe has not fully penetrated the abdominal wall. When a NULL signal is present, it is probable that the probe has penetrated the abdominal wall and that electrodes 20A-C are in the same medium, i.e., within the abdominal cavity.
It is understood that the circuit depicted in Figure 2 is merely illustrative and can be modified in any number of ways to function equivalently. One skilled in the art will also appreciate the various combination the reference electrodes 20A-C can be applied to the two comparators A, B. Additionally, as few as two electrodes can be employed by the present invention to measure the difference in impedance. In a preferred embodiment, three electrodes 20A-C are used.
Figures 3-5 depict cross-sectional side views of the abdominal wall 80, and the penetration thereof by probe 12. The side views show several fundamental structures of the abdominal wall, and the tissue components depicted in Figures 3-5 are only meant to illustrate the operating environment of the present invention. Referring to Figure 3, the abdominal wall 80 generally comprises skin 52, fat 54, and peritoneum 58. The abdominal cavity 56 and an internal abdominal structure 72 (e.g., the intestine) are also illustrated. To insert the insufflation 12 into the abdomen, the blunt end of the inner cannula 16 is pressed against the skin 52 of the abdominal wall 80. The needle 12 is then thrust downwardly, thereby disposing the inner cannula in the retracted position, while simultaneously exposing the cutting tip 18 of the outer cannula 14 to the skin 52. The cutting tip 18 of the needle 12 pierces the skin 52 and fat 54 as it travels downwardly towards the cavity 56 (see Figure 4). The needle then passes through the peritoneum 58 and into the abdominal cavity 56. Once the needle passes through the peritoneum 58, the axial load that biases the inner cannula 16 in the retracted position is removed, and the biasing mechanism 24 propels the inner cannula downward into the abdominal cavity 56, as shown by the arrow in Figure 5. The inner cannula 16 is then disposed in the extended position, exposing the side port hole 40. A gas is then insufflated into the cavity 56 through the port hole 40.
As the probe 12 passes through different types of biological tissue, the reference electrodes 20A-C measure the impedance of the tissue adjacent each respective electrode. Since different biological tissue types possess different inherent impedances, the three comparators A,B,C can detect different levels of impedance. For example, as the insufflation needle passes through the abdomen, the electrodes 20A-C are in contact with different biological tissue representative of different levels of impedance. Referring to Figure 4, electrode 20C can contact fat 54, while electrode 20B contacts skin 52, and electrode 20A contacts a gas. The electrodes 20A-C thus convey different impedance values to the input terminals of comparators A and B of Figure 2. As a result, the impedance signals 66 and 68 correspond to different impedance values, and the comparator C will generate a non-NULL signal.
Once the probe 12 is thrust entirely through the abdomen and into the abdominal cavity, the reference electrodes 20A-C will be exposed to a homogenous biological medium, as shown in Figure 5. This homogeneity of medium results in a NULL signal being generated by comparator C, since the reference electrodes 20A-C are measuring the same impedance level. The generation of a NULL signal actuates the evaluation element 44. The evaluation element 44 then either sounds an audible alarm or trips a visible light.
Either one of these events informs the surgeon that the abdominal cavity 56 has been reached. If the surgeon continues to drive the probe 12 into the patient, electrode 20C will eventually contact an internal organ, producing a nonhomogenous environment. This nonhomogeneity of medium results in a non-NULL signal being generated by comparator C, since the reference electrodes 20A-C are again measuring different impedance levels.
From the foregoing, the advantages of this invention are apparent and obvious. A disposable insufflation needle 12 can be used to pierce the abdominal wall and be positioned within the abdominal cavity, while simultaneously ensuring that internal structures are not damaged. The protection of internal organs is accomplished by the system of the present invention. Thus, during insertion of the needle 12, the reference electrodes 20A-C measure the impedance of the tissue adjacent the distal end of the outer cannula 14. The surgeon inserts the needle 12 until the comparator C generates a NULL signal indicative of a homogenous medium, e.g., placement within the abdominal cavity. The NULL signal actuates the evaluation element 44 which, in turn, trips an audible or visual alarm.
It will also be apparent to one of ordinary skill in the art that the invention can be used to monitor the progress of the probe 12 through different tissue types and different tissue types. That is changes in impedance will indicate passage through fat tissue, muscle tissue, connective tissue, and other tissue types.
In accordance with the above description, the invention attains the objects set forth. It is further intended that all matter and the description and drawings be interpreted as illustrative and not in a limiting sense. While various embodiments of the invention have been described in detail, other alteration obvious to those skilled in the art are intended to be embraced within the spirit and scope of the invention. For example, the number of electrodes used to measure the impedance of biological tissue may vary. Similarly, the number of comparators employed can be changed. The invention is to be defined, therefore, not by the preceding detailed description but by the claims that follow.
What is claimed as new and desired to be secured by Letters Patent is:

Claims

1. A diagnostic impedance measuring system comprising: an elongate probe member having a distal end and a proximal end; a plurality of axially spaced reference electrodes disposed about the distal end of the probe member; means for supplying a diagnostic level of energy to the electrodes; first comparator means for comparing the measured impedance adjacent at least a first and a second of the reference electrodes and generating a first signal indicative of the impedance difference therebetween; second comparator means for comparing the measured impedance adjacent either the first or second reference electrode and one additional reference electrode, and generating a second signal indicative of the impedance difference therebetween; third comparator means for comparing the first and second signals and generating a third signal indicative of the impedance difference between the first and second signals; and means for evaluating the third signal to determine the relative position of the probe within a patient's body.
2. The system of claim 1 wherein the probe comprises an insufflation needle.
3. The system of claim 1 wherein the means for supplying diagnostic level of energy to the electrodes communicates with an electrosurgical generator.
4. The system of claim 1 wherein the third signal indicative of the impedance difference between the first and second signals is: a NULL signal indicating that the difference in impedance between the first and second signals is zero, or a non-NULL signal indicating that the impedance difference between the first and second signals is greater or less than zero.
5. The system of claim 4 wherein the means for evaluating the third signal generates an audible signal when the third signal is a non-NULL signal.
6. The system of claim 1 wherein the voltage delivered across the reference electrodes is in the range of 0.5 to 3.0 volts.
7. The system of claim 1 wherein the current delivered through the reference electrodes is in the range of 1.0 mA to 10 mA.
8. The system of claim 2 wherein three reference electrodes are positioned at the distal end of the insufflation needle and are axially spaced apart from each other by about 2 to 6 mm.
9. A diagnostic impedance measuring system for determining the relative position within a patient's body of a tissue penetrating probe having a proximal end and a distal end, comprising: an electrosurgical generator; a plurality of axially spaced reference electrodes disposed upon a distal end of the probe; comparator means in electrical communication with the reference electrodes for comparing the impedance measured adjacent the electrodes and generating an output signal indicative of the impedance difference; and means for evaluating said output signal to determine the relative position of the probe within the patient's body.
10. The system of claim 9 wherein the electrosurgical generator delivers a diagnostic level of energy to the reference electrodes.
11. The system of claim 9 wherein the output signal indicative of the impedance difference is: a NULL signal indicating that the impedance difference is zero, or a non-NULL signal indicating that the impedance difference is greater or less than zero.
12. The system of claim 11 wherein the means for evaluating the output signal generates an audible signal when the output signal is a non-NULL signal.
13. The system of claim 9 wherein the voltage delivered across the reference electrodes is in the range of 0.5 to 3.0 volts.
14. The system of claim 9 wherein the current delivered through the reference electrodes is in the range of 1.0 mA to 10 mA.
15. A diagnostic impedance measuring device comprising: an elongate probe member having a distal end and a proximal end; a plurality of axially spaced reference electrodes disposed about the distal end of the probe member; means for supplying a diagnostic level of energy to the electrodes; first comparator means for comparing the measured impedance adjacent at least a first and a second of the reference electrodes and generating a first signal indicative of the impedance difference therebetween; second comparator means for comparing the measured impedance adjacent i either the first or second reference electrode and one additional reference electrode, and generating a second signal indicative of the impedance difference therebetween; and third comparator means for comparing the first and second signals and generating a third signal indicative of the impedance difference between the first and second signals.
16. The system of claim 15 wherein the means for supplying diagnostic energy to the electrodes communicates with an electrosurgical generator.
17. The system of claim 15 wherein the third signal indicative of the impedance difference between the first and second signals is: a NULL signal indicating that the difference in impedance between the first and second signals is zero, or a non-NULL signal indicating that the difference in impedance between the first and second signals is greater or less than zero.
18. The system of claim 15 wherein the voltage delivered across the reference electrodes is in the range of 0.5 to 3.0 volts.
19. The system of claim 15 wherein the current delivered through the reference electrodes is in the range of 1.0 mA to 10 mA.
20. The system of claim 22 wherein the probe is an insufflation needle.
21. The system of claim 20 wherein three reference electrodes are positioned at the distal end of the insufflation needle and are axially spaced apart from each other by about 2 to
6 mm.
PCT/US1994/004035 1993-04-30 1994-04-13 Diagnostic impedance measuring system WO1994024932A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU66655/94A AU6665594A (en) 1993-04-30 1994-04-13 Diagnostic impedance measuring system

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/056,364 US5335668A (en) 1993-04-30 1993-04-30 Diagnostic impedance measuring system for an insufflation needle
US08/056,364 1993-04-30

Publications (2)

Publication Number Publication Date
WO1994024932A1 true WO1994024932A1 (en) 1994-11-10
WO1994024932B1 WO1994024932B1 (en) 1994-12-22

Family

ID=22003907

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1994/004035 WO1994024932A1 (en) 1993-04-30 1994-04-13 Diagnostic impedance measuring system

Country Status (3)

Country Link
US (1) US5335668A (en)
AU (1) AU6665594A (en)
WO (1) WO1994024932A1 (en)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5697882A (en) 1992-01-07 1997-12-16 Arthrocare Corporation System and method for electrosurgical cutting and ablation
US6102046A (en) * 1995-11-22 2000-08-15 Arthrocare Corporation Systems and methods for electrosurgical tissue revascularization
US5683366A (en) * 1992-01-07 1997-11-04 Arthrocare Corporation System and method for electrosurgical tissue canalization
US5807393A (en) * 1992-12-22 1998-09-15 Ethicon Endo-Surgery, Inc. Surgical tissue treating device with locking mechanism
US5558671A (en) * 1993-07-22 1996-09-24 Yates; David C. Impedance feedback monitor for electrosurgical instrument
US5693051A (en) * 1993-07-22 1997-12-02 Ethicon Endo-Surgery, Inc. Electrosurgical hemostatic device with adaptive electrodes
US5997533A (en) * 1998-01-30 1999-12-07 Ethicon Endo-Surgery, Inc. RF pressure activated instrument
US6337994B1 (en) * 1998-04-30 2002-01-08 Johns Hopkins University Surgical needle probe for electrical impedance measurements
US7276063B2 (en) 1998-08-11 2007-10-02 Arthrocare Corporation Instrument for electrosurgical tissue treatment
US6882879B2 (en) * 2000-07-19 2005-04-19 Innovamedica S.A. De C.V. Impedance spectroscopy system and catheter for ischemic mucosal damage monitoring in hollow viscous organs
US6564079B1 (en) 2000-07-27 2003-05-13 Ckm Diagnostics, Inc. Electrode array and skin attachment system for noninvasive nerve location and imaging device
US6714806B2 (en) 2000-09-20 2004-03-30 Medtronic, Inc. System and method for determining tissue contact of an implantable medical device within a body
US6709380B2 (en) * 2001-05-31 2004-03-23 Neoseed Technology Llc Brachytherapy needle with impedance measurement apparatus and methods of use
US6723040B2 (en) * 2001-08-20 2004-04-20 International Development Consultants Bowel probe & method for controlling bowel incontinence
US7429258B2 (en) * 2001-10-26 2008-09-30 Massachusetts Institute Of Technology Microneedle transport device
US6843766B1 (en) * 2002-12-21 2005-01-18 X-L Synergy Fecal incontinence management device
EP1651127B1 (en) 2003-07-16 2012-10-31 Arthrocare Corporation Rotary electrosurgical apparatus
WO2005118060A2 (en) * 2004-04-30 2005-12-15 Boston Scientific Limited Apparatus with partially insulated needle for measuring tissue impedance and method using same
US20060079841A1 (en) * 2004-10-07 2006-04-13 University Technologies International Inc. Rapid insufflation drug compartment
US7885707B2 (en) 2005-09-15 2011-02-08 St. Jude Medical, Atrial Fibrillation Division, Inc. Method of scaling navigation signals to account for impedance drift in tissue
US20090036794A1 (en) * 2005-12-29 2009-02-05 Rikshospitalet-Radiumhospitalet Hf Method and apparatus for determining local tissue impedance for positioning of a needle
US9585586B2 (en) 2006-12-29 2017-03-07 St. Jude Medical, Atrial Fibrillation Division, Inc. Navigational reference dislodgement detection method and system
US9220439B2 (en) 2006-12-29 2015-12-29 St. Jude Medical, Atrial Fibrillation Division, Inc. Navigational reference dislodgement detection method and system
US8374673B2 (en) 2007-01-25 2013-02-12 Warsaw Orthopedic, Inc. Integrated surgical navigational and neuromonitoring system having automated surgical assistance and control
US7987001B2 (en) 2007-01-25 2011-07-26 Warsaw Orthopedic, Inc. Surgical navigational and neuromonitoring instrument
SE532140C2 (en) * 2007-09-28 2009-11-03 Clinical Laserthermia Systems Device for positioning implantable leads
FI20075978A0 (en) * 2007-12-31 2007-12-31 Katja Paassilta Arrangement and method
US8747400B2 (en) 2008-08-13 2014-06-10 Arthrocare Corporation Systems and methods for screen electrode securement
FR2939199B1 (en) * 2008-12-02 2011-02-11 C2 Diagnostics METHOD AND DEVICE FOR FLOW CYTOMETRY WITHOUT SAGING FLUID
US8355799B2 (en) 2008-12-12 2013-01-15 Arthrocare Corporation Systems and methods for limiting joint temperature
US8317786B2 (en) 2009-09-25 2012-11-27 AthroCare Corporation System, method and apparatus for electrosurgical instrument with movable suction sheath
US8323279B2 (en) 2009-09-25 2012-12-04 Arthocare Corporation System, method and apparatus for electrosurgical instrument with movable fluid delivery sheath
US8845631B2 (en) 2010-04-28 2014-09-30 Medtronic Ablation Frontiers Llc Systems and methods of performing medical procedures
US8696659B2 (en) 2010-04-30 2014-04-15 Arthrocare Corporation Electrosurgical system and method having enhanced temperature measurement
US9597482B2 (en) 2012-06-18 2017-03-21 Smart Iv Llc Apparatus and method for monitoring catheter insertion
US8700133B2 (en) 2012-06-18 2014-04-15 Smart Iv Llc Apparatus and method for monitoring catheter insertion
WO2014016765A2 (en) * 2012-07-24 2014-01-30 Lavy Lev Multilayer coaxial probe for impedance spatial contrast measurement
PL226423B1 (en) * 2012-12-21 2017-07-31 Bumar Elektronika Spółka Akcyjna Probe measuring system
US9526556B2 (en) 2014-02-28 2016-12-27 Arthrocare Corporation Systems and methods systems related to electrosurgical wands with screen electrodes
US9943682B2 (en) 2014-05-06 2018-04-17 Medtronic, Inc. Method and apparatus for determining suitability of a lead implant location
US9649148B2 (en) 2014-07-24 2017-05-16 Arthrocare Corporation Electrosurgical system and method having enhanced arc prevention
US9597142B2 (en) 2014-07-24 2017-03-21 Arthrocare Corporation Method and system related to electrosurgical procedures
US10293129B2 (en) 2016-03-07 2019-05-21 Hansa Medical Products, Inc. Apparatus and method for forming an opening in patient's tissue
US10143839B1 (en) 2017-07-05 2018-12-04 Medtronic, Inc. Lead navigation guidance
US11701494B2 (en) 2017-07-07 2023-07-18 University of Pittsburgh—of the Commonwealth System of Higher Education Catheter insertion systems
US10898720B2 (en) 2017-10-17 2021-01-26 Medtronic, Inc. Impedance sensing
EP3790461A4 (en) * 2018-05-10 2022-03-02 University of Pittsburgh - Of the Commonwealth System of Higher Education Sensing cannula systems
US11246637B2 (en) 2020-05-11 2022-02-15 Alphatec Spine, Inc. Stimulating targeting needle

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4193408A (en) * 1976-03-05 1980-03-18 Shirota Electric Furnace Material Co., Ltd. Endodontic therapy instrument
US5109870A (en) * 1988-10-25 1992-05-05 Forschungsgesellschaft Fur Biomedizinische Technik E.V. Apparatus for and method of motility and peristalsis monitoring

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3480003A (en) * 1967-02-03 1969-11-25 Battelle Development Corp Apparatus for measuring esophageal motility
US3913583A (en) * 1974-06-03 1975-10-21 Sybron Corp Control circuit for electrosurgical units
DE2504280C3 (en) * 1975-02-01 1980-08-28 Hans Heinrich Prof. Dr. 8035 Gauting Meinke Device for cutting and / or coagulating human tissue with high frequency current
US4126137A (en) * 1977-01-21 1978-11-21 Minnesota Mining And Manufacturing Company Electrosurgical unit
DE2801833C2 (en) * 1978-01-17 1979-11-29 Aesculap-Werke Ag Vormals Jetter & Scheerer, 7200 Tuttlingen Electrosurgical cutting device
DE3120102A1 (en) * 1981-05-20 1982-12-09 F.L. Fischer GmbH & Co, 7800 Freiburg ARRANGEMENT FOR HIGH-FREQUENCY COAGULATION OF EGG WHITE FOR SURGICAL PURPOSES
US4535773A (en) * 1982-03-26 1985-08-20 Inbae Yoon Safety puncturing instrument and method
US4498481A (en) * 1982-09-28 1985-02-12 Lemke Judith K Estrus cycle monitoring system
EP0126814B1 (en) * 1983-05-24 1988-12-21 Sien-Shih Chang Electro-surgical unit control apparatus
US4658819A (en) * 1983-09-13 1987-04-21 Valleylab, Inc. Electrosurgical generator
DE3413631A1 (en) * 1984-04-11 1985-10-24 Semm, Kurt, Prof. Dr.Med., 2300 Kiel MONOFILE DEVICE FOR INSUFFLING GAS
US4630615A (en) * 1984-05-21 1986-12-23 Cordis Corporation Apparatus for measuring impedance
US4729385A (en) * 1985-10-23 1988-03-08 American Mediscan, Inc. Probe and method of use for detecting abnormal tissues
US4712544A (en) * 1986-02-12 1987-12-15 Castle Company Electrosurgical generator
DE3611018C1 (en) * 1986-03-27 1987-06-19 Wiest Peter P Insufflation device for gas
DE3775281D1 (en) * 1986-06-16 1992-01-30 Siemens Ag DEVICE FOR CONTROLLING A HEART PACER BY MEANS OF IMPEDANCE ON BODY TISSUES.
DE3718717A1 (en) * 1987-06-04 1988-12-22 Wolf Gmbh Richard DEVICE FOR INSUFFLING GAS INTO A BODY CAVE
US4934377A (en) * 1987-11-24 1990-06-19 The Cleveland Clinic Foundation Intraoperative neuroelectrophysiological monitoring system
US4869717A (en) * 1988-04-25 1989-09-26 Adair Edwin Lloyd Gas insufflation needle with instrument port
US4911174A (en) * 1989-02-13 1990-03-27 Cardiac Pacemakers, Inc. Method for matching the sense length of an impedance measuring catheter to a ventricular chamber
CA2065711A1 (en) * 1991-04-10 1992-10-11 Walter S. Hennig Energy dissipation device
US5190517A (en) * 1991-06-06 1993-03-02 Valleylab Inc. Electrosurgical and ultrasonic surgical system

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4193408A (en) * 1976-03-05 1980-03-18 Shirota Electric Furnace Material Co., Ltd. Endodontic therapy instrument
US5109870A (en) * 1988-10-25 1992-05-05 Forschungsgesellschaft Fur Biomedizinische Technik E.V. Apparatus for and method of motility and peristalsis monitoring

Also Published As

Publication number Publication date
AU6665594A (en) 1994-11-21
US5335668A (en) 1994-08-09

Similar Documents

Publication Publication Date Title
US5335668A (en) Diagnostic impedance measuring system for an insufflation needle
KR0145453B1 (en) Electrosurgical trocar control device
US6569160B1 (en) System and method for detecting electrode-tissue contact
US6546270B1 (en) Multi-electrode catheter, system and method
US5078714A (en) Method and apparatus for placement of a probe in the body and the medical procedure for guiding and locating a catheter or probe in the body
US20090036794A1 (en) Method and apparatus for determining local tissue impedance for positioning of a needle
US20070255220A1 (en) Bodily fluid space entry detection method
US6440118B2 (en) Device and method to sense body substance transition
US20050171522A1 (en) Transurethral needle ablation system with needle position indicator
US20040143261A1 (en) Surgical device with pressure monitoring ability
US20120130269A1 (en) Integrated nerve stimulation and skin marking device and methods of using same
WO1993009725A1 (en) Method and apparatus for guiding a catheter
WO1994000060A1 (en) An electrosurgical tubular trocar
JP2000504971A (en) Measurement system for monitoring channel depth during percutaneous revascularization of the heart
JP2004242936A (en) Puncture needle
EP2194895A1 (en) Tissue identification method and device
US20210259573A1 (en) Tissue detection devices, systems and methods
CN113490451A (en) Devices, systems, and methods for tissue analysis, location determination, and tissue ablation
CN115227350A (en) Spine probe monitoring system and method

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AU CA JP

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase
122 Ep: pct application non-entry in european phase
122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: CA